Literature DB >> 29924197

Optical coherence tomography (OCT) angiography of central retinal artery occlusion in the patent cilioretinal artery: a case report.

Luis Filipe Nakayama1, Vinicius Campos Bergamo1, Leticia Sant'ana Cardoso Silva1, Nilva Simeren Bueno Moraes1.   

Abstract

Here we report the case of a 78-year-old male patient with a 2-day history of low visual acuity and fundus and who was diagnosed with central retinal artery occlusion. In addition, the patient had an allergy to fluorescein. A fundus examination of the left eye found a pink optic disc with blurred margins, diffuse pallor in the retina with arterial attenuation, and a normal band of the retinal area in the macular region. Optical coherence tomography revealed increased thickness of the inner retina. Optical coherence tomography angiography (OCT-A) revealed a decreased flow signal in the superficial layers, with reduced flow signal in the choriocapillaris. OCT-A is a valuable alternative during the follow-up period in patients with central retinal artery occlusion, particularly in those with an allergy to contrast agents. The use of this as a non-invasive examination can improve the prognosis of patients and future studies investigating the treatment of central retinal artery occlusion.

Entities:  

Mesh:

Year:  2018        PMID: 29924197     DOI: 10.5935/0004-2749.20180048

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  2 in total

1.  Central retinal artery occlusion and optic neuropathy secondary to platelet rich plasma injection: a case report.

Authors:  Norashikin Maslan; Wan Haslina Wan Abdul Halim; Norshamsiah Md Din; Seng Fai Tang
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

2.  Paracentral acute middle maculopathy in the setting of central retinal artery occlusion following COVID-19 diagnosis.

Authors:  Neslihan Turedi; Betul Onal Gunay
Journal:  Eur J Ophthalmol       Date:  2021-02-14       Impact factor: 1.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.